In an era marked by unprecedented advancements in medical science and technology, ensuring equitable access to life-saving medicines remains a global imperative. The equitable licensing of medicines and biologics plays a pivotal role in addressing the complex challenges that limit access to essential medications across the world. This panel discussion brings together experts from diverse backgrounds to explore the multifaceted dimensions of equitable licensing considerations for access to medicines.

The panel will delve into various aspects of equitable licensing, including the legal, ethical, economic, and social dimensions. Some key themes to be addressed include the role of intellectual property rights, compulsory licensing, technology transfer, and international agreements in shaping the availability and affordability of medicines. Additionally, the discussion will explore how equitable licensing can bridge the gap between research and development, production, and global distribution of pharmaceuticals.

Ultimately, this panel aims to foster a robust dialogue on equitable licensing as a means to not only overcome barriers to medicine access but also as a driver for innovation, collaboration, and the pursuit of health equity. It invites participants to consider the ethical imperative of ensuring that the benefits of medical progress are shared by all, regardless of geographic location or economic status.

Read about the Speakers here.